Symbol="ENOB"
AssetType="Common Stock"
Name="Enochian Biosciences Inc"
Description="Enochian Biosciences, Inc., a preclinical-stage biotechnology company, focuses on the development of human therapies for infectious diseases and cancers. The company is headquartered in Los Angeles, California."
CIK="1527728"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="DANDRIT BIOTECH A/S, FRUEBJERGVEJ 3 BOX 62, 2100 COPENHAGEN, DK"
FiscalYearEnd="June"
LatestQuarter="2023-03-31"
MarketCapitalization="33539600"
EBITDA="-20464270"
PERatio="None"
PEGRatio="None"
BookValue="1.14"
DividendPerShare="0"
DividendYield="0"
EPS="-2.44"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.0994"
ReturnOnEquityTTM="-0.939"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.44"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.45"
EVToRevenue="-"
EVToEBITDA="-1.727"
Beta="1.099"
num_52WeekHigh="2.99"
num_52WeekLow="0.393"
num_50DayMovingAverage="0.871"
num_200DayMovingAverage="1.277"
SharesOutstanding="63698000"
DividendDate="None"
ExDividendDate="None"
symbol="ENOB"
open="0.48"
high="0.55"
low="0.44"
price="0.47"
volume="158540.00"
latest_trading_day="2023-07-07"
previous_close="0.46"
change="0.02"
change_percent="3.5011%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="72"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="28"
Volume_recent_avg="105012"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-1.83"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="28"
Aroon_momentum_negative="72"
image_negative_thumbnail_id_1="519"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0086.jpeg"
image_negative_thumbnail_id_2="1151"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0184.jpeg"
image_neutral_thumbnail_id_1="537"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_neutral_thumbnail_id_2="593"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0006.jpeg"
image_positive_thumbnail_id_1="973"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0135.jpeg"
image_positive_thumbnail_id_2="637"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
